We vet deals like investors should
Blackpine connects healthcare founders with capital and strategic support that actually matters beyond the check.
Who evaluates your deal before the capital arrives?
Blackpine's team brings deep healthcare and technology expertise, founder experience, and investor networks. We vet every opportunity with rigor, not sales instinct.
Founder vetting
We evaluate your science, market fit, and execution risk using the same lens investors apply. No theater.
Investor matching
We connect founders to investors whose thesis and experience align with your stage and sector.
Healthcare sector knowledge
Our team understands regulatory pathways, reimbursement mechanics, and clinical validation. We speak the language.
Post-raise support
Capital is just chapter one. We guide strategy, introduce operational advisors, and help navigate early scaling.
The conversations that move deals forward
Founders and investors tell us what shifts when expert vetting meets real partnership. These aren't polish. They're specifics.
Blackpine didn't just connect us with capital. They understood the science behind our technology and helped us articulate why investors should care. The vetting process felt like due diligence, not a sales funnel.
Dr. Sarah Chen
Founder and CEO, medtech startup
We work with a lot of deal platforms. Blackpine's approach to vetting actually flags the signal from the noise. The founders they surface are vetted. That changes how we allocate time.
Michael Torres
Investment partner, healthcare-focused fund
What struck us most: Blackpine stayed involved after the capital closed. That's rare. They helped us think through regulatory hurdles and investor relations in ways that actually mattered to our growth trajectory.
Lisa Patel
Co-founder, digital health platform
The founder quality coming through Blackpine's network is measurably higher. They do the homework upfront so we don't have to waste time on deals that don't fit. That's how you build a portfolio efficiently.
David Kim
General partner, venture capital firm
Alira Health backs more than the check
We evaluate the science, not just the pitch. Our vetting process filters signal from noise so investors see what matters. For founders, that means a partner who understands your market, your data, and your path to scale beyond the initial raise.
50+ healthcare and technology companies have partnered with Blackpine
We connect founders and investors through Alira Health's network. Our partnerships span life sciences, digital health, and medical device innovation across the United States.
What founders and investors actually need to know
Real answers about how Blackpine works and what happens after the capital arrives.
How does Blackpine help founders beyond just raising capital?
We vet your pitch, connect you with investors who understand healthcare, and then stick around. Post-raise, we help you navigate regulatory hurdles, build your board, and solve the problems capital alone can't fix. Most founders' real obstacles start after closing.
What kind of companies does Blackpine work with?
Healthcare innovators and technology companies solving real problems in medical devices, diagnostics, digital health, and therapeutic solutions. We're looking for founders with proof points—working prototypes, pilot data, or early traction. You don't need to be perfect. You need to be credible.
How do you vet opportunities for investors?
We run technical due diligence on the science, assess market sizing and competitive positioning, and evaluate the founding team's execution capability. We're not a rubber stamp. If it doesn't hold up, investors hear why. That's our value to them.
What's the timeline for getting funded through Blackpine?
Initial vetting takes 2 to 4 weeks. If we move forward, introductions to investors happen in parallel with closing our process. Total time from submission to first investor meeting is typically 6 to 8 weeks. Closing depends on your deal and the investor.
Do you only work with institutional investors, or do you have angel networks?
Both. Our investor base includes family offices, strategic investors, and specialized healthcare funds. For some founders, the right investor is a strategic corporate buyer. We match the capital source to your stage and what you actually need.
What does it cost to work with Blackpine?
For founders, there's no upfront fee. For investors using our platform, we structure deal-contingent economics. We only win when you close. We're transparent about all terms before you engage.
Ready to talk specifics?
Get on a call with our team and let's see if Blackpine is the right fit.